U.S. FDA Approves Pfizer's VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC) - Pfizer pfizer.com Submitted by pfizercom6279 on October 14, 2023 at 2:09 PM in business No comments 53